Chemoinformaics analysis of S-methyl cysteine sulfoxide (methiin)
| Molecular Weight | 151.187 | nRot | 3 |
| Heavy Atom Molecular Weight | 142.115 | nRig | 1 |
| Exact Molecular Weight | 151.03 | nRing | 0 |
| Solubility: LogS | -0.899 | nHRing | 0 |
| Solubility: LogP | -3.043 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 19.0871 |
| nHD | 2 | BPOL | 13.8849 |
| QED | 0.495 |
| Synth | 4.768 |
| Natural Product Likeliness | 0.65 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.952 |
| HIA | 0.013 |
| CACO-2 | -5.845 |
| MDCK | 0.000772375 |
| BBB | 0.311 |
| PPB | 0.0783487 |
| VDSS | 0.433 |
| FU | 0.875512 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.07 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.011 |
| CYP2c9-sub | 0.507 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.19 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.032 |
| CL | 4.29 |
| T12 | 0.662 |
| hERG | 0.013 |
| Ames | 0.229 |
| ROA | 0.066 |
| SkinSen | 0.205 |
| Carcinogencity | 0.82 |
| EI | 0.092 |
| Respiratory | 0.133 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.948917 |